Literature DB >> 28461847

Immune reconstitution inflammatory syndrome in a HIV-infected patient with disseminated tuberculosis.

K C Koh1, J W Pak2.   

Abstract

Immune reconstitution inflammatory syndrome (IRIS) is the paradoxical worsening of pre-existing infectious processes after commencement of anti-retroviral therapy (ART) in HIV-infected patients. Its manifestations are dependent on the underlying opportunistic infections. We report a case of an HIV-infected patient with disseminated tuberculosis, who responded to anti-tuberculosis therapy but suffered from paradoxical worsening after commencement of ART.

Entities:  

Keywords:  HIV; Immune reconstitution inflammatory syndrome; antiretroviral therapy; tuberculosis

Year:  2016        PMID: 28461847      PMCID: PMC5405331     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  18 in total

Review 1.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

Review 2.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

Review 3.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

4.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

5.  Integration of antiretroviral therapy with tuberculosis treatment.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L Gray; Tanuja Gengiah; Santhanalakshmi Gengiah; Anushka Naidoo; Niraksha Jithoo; Gonasagrie Nair; Wafaa M El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

6.  Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis.

Authors:  Joshua T Schiffer; Timothy R Sterling
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

7.  Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

Authors:  Guillaume Breton; Xavier Duval; Candice Estellat; Xavier Poaletti; Daniel Bonnet; David Mvondo Mvondo; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Journal:  Clin Infect Dis       Date:  2004-11-09       Impact factor: 9.079

8.  Immune reconstitution inflammatory syndrome: risk factors and treatment implications.

Authors:  Yukari C Manabe; James D Campbell; Emily Sydnor; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

9.  Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.

Authors:  David M Murdoch; Willem D F Venter; Charles Feldman; Annelies Van Rie
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

10.  Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.

Authors:  Judith A Aberg; Peter V Chin-Hong; Allen McCutchan; Susan L Koletar; Judith S Currier
Journal:  Clin Infect Dis       Date:  2002-06-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.